Epogen

Epoetin alfa

Epoetin
Epoetin alfa is human erythropoietin produced in cell culture using recombinant DNA technology. It stimulates erythropoiesis and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Epoetin is marketed under the trade names Procrit and Epogen. Its annual cost to U.S. patients is $8,447

Epogen - List of case studies

Myelodysplastic syndrome (MDS), with kariotype del(11)q(11)

erythopoietin injections ( Procrit, Aranesp, Epogen ) may help support the red blood cells. Sometimes this is given with ... erythopoietin injections (Procrit, Aranesp, Epogen), G-CSF (Neupogen), lenalidomide (Revlimid), Vidaza, Dacogen, ...

MDS – Myelodysplastic Syndrome

supervenes, erythopoietin injections (Procrit, Aranesp, Epogen) may help support the red blood cells . Sometimes this is given with ... blocker, chemotherapy, erythropoietin, Procrit, Aranesp, Epogen, G-CSF, Neupogen, lenalidomide, Revlimid, Vidaza, Dacogen, Azacitidine. ...

Drugs

steroid injection Epinephrine Epirubicin Epogen Epogen) Erbitux Erlotinib Erythopoietin injections (Procrit ...

JustAnswer.com